Drugs · acquisition-cost intelligence
Desoximetasone
· ingredient desoximetasoneCorticosteroids, potent, other combinations· DESOXIMETASONE 2.5 mg/g; DESOXIMETASONE .5 mg/g
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per GM
$0.91251
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per GM — the trend nobody else shows. 7 weeks.
2025-02-192026-05-20
Same-ingredient options by acquisition cost
Other desoximetasone products, cheapest acquisition cost first. Per GM — confirm strength/form equivalence before switching.
| Product | NADAC / GM | vs this |
|---|---|---|
| desoximetasone | $0.32237 | −$0.59010 |
| desoximetasone | $0.40958 | −$0.50290 |
| Topicort | $0.56343 | −$0.34910 |
| Topicort | $1.04 | +$0.12900 |
Medicare Part D coverage · CY2026
On 71 plan formularies · typical tier 4
Prior auth 0% · Step therapy 0% · Quantity limit 47% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.